These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26637231)

  • 21. Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer.
    Tas F; Duranyildiz D; Argon A; Oğuz H; Camlica H; Yasasever V; Topuz E
    Med Oncol; 2005; 22(4):353-8. PubMed ID: 16260852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy.
    Chang CH; Hsiao CF; Yeh YM; Chang GC; Tsai YH; Chen YM; Huang MS; Chen HL; Li YJ; Yang PC; Chen CJ; Hsiung CA; Su WC
    Int J Cancer; 2013 May; 132(9):1977-85. PubMed ID: 23034889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neopterin serum levels in pancreatic adenocarcinoma.
    Manes G; Spada OA; Rabitti PG; Feola B; Misso S; Minerva A; Uomo G
    Int J Pancreatol; 1999 Feb; 25(1):31-7. PubMed ID: 10211419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of serum parameters panels for the early detection of pancreatic cancer.
    Zhang P; Zou M; Wen X; Gu F; Li J; Liu G; Dong J; Deng X; Gao J; Li X; Jia X; Dong Z; Chen L; Wang Y; Tian Y
    Int J Cancer; 2014 Jun; 134(11):2646-55. PubMed ID: 24615168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-8, a promising predictor for prognosis of pancreatic cancer.
    Chen Y; Shi M; Yu GZ; Qin XR; Jin G; Chen P; Zhu MH
    World J Gastroenterol; 2012 Mar; 18(10):1123-9. PubMed ID: 22416189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
    Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma.
    Tas F; Oguz H; Argon A; Duranyildiz D; Camlica H; Yasasever V; Topuz E
    Med Oncol; 2005; 22(3):241-6. PubMed ID: 16110135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of interleukine-8 as an independent prognostic factor for sporadic colon cancer dissemination.
    Nastase A; Paslaru L; Herlea V; Ionescu M; Tomescu D; Bacalbasa N; Dima S; Popescu I
    J Med Life; 2014 Jun; 7(2):215-9. PubMed ID: 25408728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum des-gamma-carboxyprothrombin in patients with pancreatic head adenocarcinoma.
    Kemik AS; Kemik O; Purisa S; Tuzun S
    Bratisl Lek Listy; 2011; 112(10):552-4. PubMed ID: 21954538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and prognostic significance of prostate specific antigen and serum interleukin 18 and 10 in patients with locally advanced prostate cancer: a prospective study.
    Dwivedi S; Goel A; Natu SM; Mandhani A; Khattri S; Pant KK
    Asian Pac J Cancer Prev; 2011; 12(7):1843-8. PubMed ID: 22126577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?
    Erturk K; Tastekin D; Bilgin E; Serilmez M; Bozbey HU; Sakar B
    Biomed Pharmacother; 2016 Feb; 77():86-91. PubMed ID: 26796270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteonectin as a screening marker for pancreatic cancer: A prospective study.
    Papapanagiotou A; Sgourakis G; Karkoulias K; Raptis D; Parkin E; Brotzakis P; Panchal S; Papavassiliou AG
    J Int Med Res; 2018 Jul; 46(7):2769-2779. PubMed ID: 29756486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of circulating cytokines for stage III colon cancer.
    Lee WS; Baek JH; You DH; Nam MJ
    J Surg Res; 2013 Jun; 182(1):49-54. PubMed ID: 23010514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of serum M30 and M65 levels in melanoma.
    Tas F; Karabulut S; Serilmez M; Yildiz I; Sen F; Ciftci R; Duranyildiz D
    Melanoma Res; 2013 Oct; 23(5):390-5. PubMed ID: 23812330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of serum D-dimer, fibrinogen, and CA19-9 for postoperative monitoring and survival prediction in resectable pancreatic carcinoma.
    Cao J; Fu Z; Gao L; Wang X; Cheng S; Wang X; Ren H
    World J Surg Oncol; 2017 Feb; 15(1):48. PubMed ID: 28219450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential prognostic significance of a new proteomic profile in patients with advanced pancreatic adenocarcinoma.
    Kobayashi S; Ueno M; Irie K; Goda Y; Aoyama T; Morinaga S; Ohkawa S; Morimoto M
    Pancreatology; 2015; 15(5):525-530. PubMed ID: 26255025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer.
    Chang YT; Chang MC; Wei SC; Tien YW; Hsu C; Liang PC; Tsao PN; Jan IS; Wong JM
    Pancreas; 2008 Aug; 37(2):145-50. PubMed ID: 18665074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
    Sun B; Liu X; Gao Y; Li L; Dong Z
    Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SERUM CYTOKINE OF IL-2, IL-10 AND IL-12 LEVELS IN PATIENTS WITH STOMACH ADENOCARCINOMA.
    Shokrzadeh M; Mohammadpour A; Hoseini V; Abediankenari S; Ghassemi-Barghi N; Tabari YS
    Arq Gastroenterol; 2018; 55(4):385-389. PubMed ID: 30785523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High serum levels of interleukin-6 in patients with advanced or metastatic colorectal cancer: the effect on the outcome and the response to chemotherapy plus bevacizumab.
    Hara M; Nagasaki T; Shiga K; Takahashi H; Takeyama H
    Surg Today; 2017 Apr; 47(4):483-489. PubMed ID: 27549777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.